ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition - Sorbonne Université Access content directly
Journal Articles Oncogene Year : 2019

ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition

Abstract

Some cancer cells elongate their telomeres through the ALT (alternative lengthening of telomeres) pathway, which is based on homologous recombination for the addition of telomere repeats without telomerase activity. General control nonderepressible 5 (GCN5) and P300/CBP-associated factor (PCAF), two homologous lysine acetyltransferases, exert opposite effects on the ALT pathway, inhibiting or favoring it respectively. Here we show that ALT cells are particularly sensitive to the inhibition of acetyltransferases activities using Anacardic Acid (AA). AA treatment recapitulates the effect of PCAF knockdown on several ALT features, suggesting that AA decreased the ALT mechanism through the inhibition of lysine transferase activity of PCAF, but not that of GCN5. Furthermore, AA specifically sensitizes human ALT cells to radiation as compared to telomerase-positive cells suggesting that the inhibition of lysine acetyltransferases activity may be used to increase the radiotherapy efficiency against ALT cancers.
Fichier principal
Vignette du fichier
2019-Bakos-Douaihy-Oncotarget.pdf (3.44 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03941150 , version 1 (16-01-2023)

Identifiers

Cite

Dalal Bakhos-Douaihy, Chantal Desmaze, Maya Jeitany, Laurent Gauthier, Denis Biard, et al.. ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition. Oncogene, 2019, 10 (7), pp.773-784. ⟨10.18632/oncotarget.26616⟩. ⟨hal-03941150⟩
40 View
12 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More